24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
89Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:06
Amdocs’ layoffs fail to halt share slide
14:04
U.S.-Iran deal to alter Israel’s strategic and economic environment
12:28
Israel needs to strengthen cybersecurity enforcement as AI speeds up attacks
11:14
Marvell CTO: "The market has finally reached the bottleneck we solve"
More stories
Buzz
Most popular
Daily
Weekly
1
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
2
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
3
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
4
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
5
Two years after a $2.7 billion return to Google, AI pioneer Noam Shazeer is leaving for OpenAI
More news
89Bio
3 stories about 89Bio
Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio
18.09.25
|
CTech
Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.
Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO
15.10.19
|
CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture
28.10.18
|
Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
